Speakers

Chris Nowers

CEO

ONK Therapeutics

Christian Capitini

Associate Professor, Pediatrics

University of Wisconsin

Michael O’Dwyer

CSO

ONK Therapeutics

Sandro Matosevic

Assistant Professor

Purdue University

Emily Levy

Postdoctoral Research Fellow, Laboratory of Transplantation Immunotherapy, NHLBI

NIH

Kurt Gunter

CMO

Kuur Therapeutics

Richard Childs

Rear Admiral, Commissioned Corps Unites States Public Health Service, NHLBI

NIH

Stephen Chen

CTO

NK Max America

Bob Valemehr

CDO

Fate Therapeutics

Mark Lowdell

CSO

Inmune Bio

Nina Shah

Chair of Scientific Advisory Board

Indapta Therapeutics

Tracey Lodie

CSO

Gamida Cell

Elie Haddad

Head, Research Axis, Immune Disorders & Cancers

CHU Sainte-Justine

Jennifer Dashnau

Head of Analytical Development & Quality Control

Century Therapeutics

Mark Wallet

VP, Head of Immunology

Century Therapeutics

Rizwan Romee

Associate Professor, Harvard Medical School

Dana Farber Cancer Institute

Jason Litten

CMO

Artiva Biotherapeutics

Marc van Dijk

CTO

AgenTus

Sylvia Lee

Senior Research Scientist

Acepodia

Xiaokui Zhang

CSO

Celularity

Chris Nowers

CEO

ONK Therapeutics

Kurt Gunter

CMO

Kuur Therapeutics

Matthew Klinker

Biologist, Cell Therapy Branch, Division of Cellular and Gene Therapies

CBER

Sonny Hsiao

Founder & CEO

Acepodia

Björn Önfelt

Associate Professor

Karolinska Institute

Hans-Gustaf Ljunggren

Professor

Karolinska Institute

Robert Hariri

CEO

Celularity

Wei Li

CSO

Cytovia Therapeutics

Daniel Teper

CEO

Cytovia Therapeutics

James Trager

CSO

Nkarta Therapeutics

Robert Igarashi

VP, Discovery & Pre-Clinical Development

Kiadis Pharma

Todd Fehniger

Associate Professor

Washington University School of Medicine in St Louis

Anahid Jewett

Professor

University of California Los Angeles

Dan Kaufman

Professor

University of California

Nick Huntington

CSO

oNKo-Innate Pty Ltd

Silke Paust

Associate Professor

Scripps Institute

Amy Sharma

Project Lead Scientist, Development

Genentech Inc.

Evren Alici

CEO

Vycellix

Jeffrey Miller

Professor

University of Minnesota